These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8456712)

  • 21. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
    Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
    Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laryngospasm after administration of gadopentetate dimeglumine.
    Omohundro JE; Elderbrook MK; Ringer TV
    J Magn Reson Imaging; 1992; 2(6):729-30. PubMed ID: 1446118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe anaphylactoid reaction after i.v. Gd-DTPA.
    Weiss KL
    Magn Reson Imaging; 1990; 8(6):817-8. PubMed ID: 2266810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical shift misregistration artifact: increased conspicuity following intravenous administration of gadopentetate dimeglumine.
    Apicella PL; Mirowitz SA; Borrello JA
    Magn Reson Imaging; 1994; 12(4):675-8. PubMed ID: 8057773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gadolinium-DTPA (Magnevist) as contrast medium for arterial DSA].
    Schild HH; Weber W; Boeck E; Mildenberger P; Strunk H; Düber C; Grebe P; Schadmand-Fischer S; Thelen M
    Rofo; 1994 Mar; 160(3):218-21. PubMed ID: 8136474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total cerebrospinal fluid enhancement following intravenous Gd-DTPA administration in a case of meningiomatosis.
    Berger B; Ortiz O; Gold A; Hilal SK
    AJNR Am J Neuroradiol; 1992; 13(1):15-8. PubMed ID: 1595433
    [No Abstract]   [Full Text] [Related]  

  • 31. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Svaland MG; Christensen T; Lundorf E
    Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
    García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
    Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical evaluation of the tolerability of gadodiamide, a new nonionic contrast agent in MRI of the central nervous system].
    Aslanian V; Lemaignen H; Bunouf P; Schiratti M; Lambrechts M; Lundby B; Borseth A; Svaland M
    J Radiol; 1995 Jul; 76(7):431-4. PubMed ID: 7473377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the safety of the standard dose and a higher dose of gadodiamide injection for MR imaging of the central nervous system.
    Svaland MG; Lundby B; Kristoffersen DT
    J Magn Reson Imaging; 1994; 4(3):419-23. PubMed ID: 8061442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An experimental model to study contrast enhancement in MR imaging of the intervertebral disk.
    Nguyen CM; Ho KC; Yu SW; Haughton VM; Strandt JA
    AJNR Am J Neuroradiol; 1989; 10(4):811-4. PubMed ID: 2505508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
    Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
    Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats.
    Masui T; Takehara Y; Aoshima R; Kaneko M
    Invest Radiol; 1994 Jun; 29 Suppl 2():S189-91. PubMed ID: 7928226
    [No Abstract]   [Full Text] [Related]  

  • 39. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of gadodiamide injection in two different age groups.
    Högström B; Kristoffersen DT; Lundby B; Svaland MG
    J Magn Reson Imaging; 1996; 6(1):255-7. PubMed ID: 8851438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.